Should Selection of Adjuvant Chemotherapy for Patients With Breast Cancer Be Based on erbB-2 Status?
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/90/18/1320/18048078/90-18-1320.pdf
Reference10 articles.
1. Human breast cancer: correlation of relapse and survival with amplification of HER-2/neu oncogene;Slamon;Science,1987
2. HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma;Allred;J Clin Oncol,1992
3. Prognostic importance of c-erbB-2 expression in breast cancer;Gusterson;International (Ludwig) Breast Cancer Study Group. J Clin Oncol,1992
4. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer [published erratum appears in N Engl J Med 1994;331: 211];Muss;N Engl J Med,1994
5. Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [published erratum appears in Controlled Clin Trials 1994;15: 326];Peterson;Controlled Clin Trials,1993
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Breast Cancer;TNM Online;2014-12-03
2. Invasive Breast Carcinoma;Pathobiology of Human Disease;2014
3. An Immunohistochemical and Fluorescence In Situ Hybridization-based Comparison Between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH Using Both Commercially Validated and Modified ASCO/CAP and United Kingdom HER2 IHC Scoring Guidelines;Applied Immunohistochemistry & Molecular Morphology;2010-12
4. Simultaneous Amplification of HER-2 (ERBB2) and Topoisomerase IIα (TOP2A) Genes - Molecular Basis for Combination Chemotherapy in Cancer;Current Cancer Drug Targets;2006-11-01
5. Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer;BMC Clinical Pathology;2006-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3